Search results for "Posterior reversible encephalopathy syndrome"

showing 5 items of 5 documents

Positive Effect of Steroids in Posterior Reversible Encephalopathy Syndrome

2019

We present a case of posterior reversible encephalopathy syndrome with severe clinical manifestation. Apart from initial aphasia, hemiparesis, and a generalized seizure, the patient had a prolonged loss of consciousness. Although blood pressure was normalized, the clinical status deteriorated continuously. After adding steroids to the therapy, the patient recovered rapidly, suggesting that this could have been a useful therapeutic approach. Even the vasogenic edema in the cerebral magnetic resonance imaging disappeared shortly within 6 days.

medicine.medical_specialtyEncephalopathyPATHOPHYSIOLOGYCase ReportEncephalopathylcsh:RC346-42903 medical and health sciencesTherapeutic approach0302 clinical medicineInternal medicineAphasiamedicineMANAGEMENT030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemSPECTRUMmedicine.diagnostic_testbusiness.industryMagnetic resonance imagingPosterior reversible encephalopathy syndromeEDEMAmedicine.diseaseBlood pressureHemiparesisPosterior reversible encephalopathy syndromeCardiologyEncephalitisNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryEncephalitis
researchProduct

Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome

2019

OncologyCobimetinibmedicine.medical_specialtyCombination therapybusiness.industryMelanomaPosterior reversible encephalopathy syndromeHematologymedicine.diseasechemistry.chemical_compoundText miningOncologychemistryInternal medicinemedicineVemurafenibbusinessmedicine.drugAnnals of Oncology
researchProduct

First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic…

2017

Recently, studies in adults with acute promyelocytic leukemia (APL) showed high cure rates in low-risk patients treated with all-trans retinoid acid (ATRA) and arsenic trioxide (ATO), while toxicities were significantly reduced compared to the standard treatment with ATRA and chemotherapy. Here we report about first experience with 11 pediatric patients with low-risk APL treated with ATRA and ATO. All patients stayed in molecular remission. All suffered from hyperleukocytosis. Two patients experienced reversible severe side effects. One suffered from osteonecroses at both femurs, seizures, as well as posterior reversible encephalopathy syndrome, the other patient had an abducens paresis.

Acute promyelocytic leukemiaMalemedicine.medical_specialtyAdolescentmedicine.drug_classmedicine.medical_treatmentMedizinTretinoinGastroenterologyArsenicals03 medical and health scienceschemistry.chemical_compound0302 clinical medicineArsenic TrioxideLeukemia Promyelocytic AcuteTretinoinInternal medicineAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansRetinoidArsenic trioxideChildneoplasmsParesisRetrospective StudiesChemotherapybusiness.industryStandard treatmentInfantPosterior reversible encephalopathy syndromeOxidesHematologymedicine.diseaseSurgeryTreatment OutcomeOncologychemistry030220 oncology & carcinogenesisChild PreschoolPediatrics Perinatology and Child HealthFemalemedicine.symptombusiness030215 immunologymedicine.drug
researchProduct

Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement

2020

Typical posterior reversible encephalopathy syndrome (PRES) is a clinical-neuroradiological entity characterised by bilateral white matter oedema, which is usually symmetrical and totally reversible in 2–3 weeks. A 46-year-old man presented with a persistent headache and visual blurring in the right eye. On admission, the clinical examination revealed minimal unsteadiness of gait and elevated blood pressure. A brain MRI showed a hyperintense signal on T2-weighted sequences in the whole brainstem, extended to the spinal cord (C2–C6), the left insula and the right cerebellum. When his blood pressure was controlled, his symptoms gradually improved. The follow-up MRI scan at 3 weeks revealed a …

Malemedicine.medical_specialtyCerebellumNeurologyNifedipinePhysical examination030218 nuclear medicine & medical imagingWhite matterDiagnosis Differential03 medical and health sciences0302 clinical medicineRamiprilmedicineHumansAntihypertensive AgentsUnusual Presentation of More Common Disease/Injuryneuroimagingmedicine.diagnostic_testbusiness.industryneurologyBrain stem/cerebellumDoxazosinPosterior reversible encephalopathy syndromeGeneral MedicineMiddle AgedSpinal cordmedicine.diseaseCalcium Channel BlockersMagnetic Resonance ImagingWhite Matterradiologymedicine.anatomical_structureSettore MED/26 - NeurologiaRadiologyBrainstemPosterior Leukoencephalopathy SyndromeDifferential diagnosisbusinessneuro-oncology030217 neurology & neurosurgeryBrain Stem
researchProduct

Posterior reversible encephalopathy syndrome revealing acute intermittent porphyria

2016

0301 basic medicinePathologymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryPosterior reversible encephalopathy syndromeMagnetic resonance imaging030105 genetics & hereditymedicine.disease03 medical and health sciences0302 clinical medicinePorphyriaNeurologyPosterior Leukoencephalopathy SyndromemedicineNeurology (clinical)Differential diagnosisbusiness030217 neurology & neurosurgeryAcute intermittent porphyriaRevue Neurologique
researchProduct